GenFlow Biosciences is a biotechnology company dedicated to increasing our understanding of the factors that controls lifespan. We research, develop and commercialize therapeutic solutions to lengthen healthspan, the amount of time we live in good health. Our mission is to create biological interventions that enable longer and healthier lives.

GENFLOW is dedicated to the development and commercialization of novel therapeutics targeting ageing in dogs and humans. Ageing is not a natural fatality.

There is no rationale for a limited lifespan. Ageing can now be considered as a risk factor that we can treat. By treating ageing, we believe that GENFLOW can contribute to decrease healthcare costs and lessen the emotional and societal burden that comes with an ageing population.

https://www.share-talk.com/eric-leire-chief-executive-officer-genflow-biosciences-interview/